Shoulder Innovations, Inc.
SI NYSE· Surgical & Medical Instruments & Apparatus
Last close · Oct 27, 2026
$19.34
KIRA · Stoqly’s AI analyst, in plain words
- Shoulder Innovations, Inc. had $47.3M of revenue in fiscal 2025, up 49.6% on the year before.
- Its operating margin was −55.6%, down 9.2 pts: of every 100 in sales, about −56 is left after running the business.
- Shoulder Innovations, Inc. lost $40.4M in fiscal 2025.
- Free cash flow was −$36.0M in fiscal 2025, −76.1% of revenue.
- Shoulder Innovations, Inc. has $109M more cash than debt.
Market cap
$401M
P/E
0.1x
Revenue
$47.3M
Net income
−$40.4M
Free cash flow
−$36.0M
Operating margin
−55.6%
Shoulder Innovations, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+49.6%
Yes. Sales grew 49.6% last year.
Does it make a profit?
−85.3%
No. It lost money last year.
Does profit turn into cash?
−76.1%
No. It spent more cash than it brought in.
How healthy are the accounts?
4 / 9
Mixed. It passes 4 of 9 health tests.
How is the share priced?
0.1x
One share costs 0.1 times its yearly profit per share.
What Shoulder Innovations, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 10, 2026
- Legal name
- SHOULDER INNOVATIONS, INC.
- CIK
- 0001699350
Shoulder Innovations, Inc. · SI
Results and finances
The last 2 fiscal years. Amounts in USD.
| Fiscal year | FY24 | FY25 |
|---|---|---|
| Sales and profit | ||
| Revenue | $31.6M | $47.3M |
| Revenue growth | — | 49.6% |
| Gross margin | 77.0% | 76.5% |
| Operating margin | −46.3% | −55.6% |
| Net income | −$15.6M | −$40.4M |
| Net margin | −49.4% | −85.3% |
| Diluted EPS | −$242.04 | −$4.65 |
| Cash | ||
| Cash from operations | −$14.1M | −$28.6M |
| Capital expenditure | $4.0M | $7.4M |
| Free cash flow | −$18.2M | −$36.0M |
| FCF margin | −57.4% | −76.1% |
| Share count change | — | 13,346.7% |
| Debt and strength | ||
| Cash and short-term investments | $15.0M | $124M |
| Debt incl. finance leases | $14.7M | $14.9M |
| Shareholders' equity | −$54.7M | $141M |
| Current ratio | 4.6x | 11.1x |
| Interest coverage | −11.1x | −375.7x |
| Returns and quality | ||
| Return on capital | — | −66.3% |
| Return on equity | — | −93.8% |
| Return on tangible equity | — | −28.7% |
| Piotroski F-score | — | 4 |
| Altman Z'' | −4.9 | 7.7 |
Insiders bought, 12 months
$0.2M
3 insiders
Insiders sold, 12 months
$5.5M
3 insiders
Of sales under plans
15%
$0.8M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Shoulder Innovations, Inc. · SI
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $19.34 a share, the company is worth $401M: 0.1 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001699350). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.